Science
Mechanism of Action
This protein hydrolysate delivers a blend of amino acids, peptides, and larger protein molecules to the skin. Its high amino acid content actively improves surface hydration and skin elasticity. Larger peptide and protein components form a protective film, which effectively reduces trans-epidermal water loss, thereby helping to maintain skin cell water content and promote a healthy complexion. Manufacturers note its role as a film-forming, protecting, and restructuring agent. Research has indicated its ability to reduce reactive oxygen species (ROS) and restore the expression of key cellular components like Nrf2, SOD1, catalase, and filaggrin (FLG) in TNF-α/IFN-γ-stimulated human keratinocytes. It also demonstrated anti-inflammatory effects by reducing markers such as IL-6, TARC, TSLP, and RANTES, inhibiting NF-κB phosphorylation, and suppressing the T helper 2 (Th2) immune response. In a mouse model, it significantly mitigated atopic dermatitis-like symptoms by reducing mast cell and macrophage infiltration, epidermal thickness, and TSLP levels, while preventing FLG downregulation. Further benefits are suggested to include faster cell regeneration, enhanced collagen production, improved moisture retention, protection against environmental damage leading to wrinkles, soothing properties for acne and redness, and contributing to the reduction of hyperpigmentation and dark spots.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Conflicts
- Must be thoroughly processed to ensure it is free of detectable pathogenic viruses or infectious agents
- Should not contain estrogenic hormones or other biologically active substances to avoid metabolic/endocrine activity
- Its use in cosmetic products is prohibited within the European Union due to safety concerns regarding disease transmission.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel concluded that available data are insufficient to support the safety of Hydrolyzed Human Placental Protein in cosmetics, specifically requesting data on skin sensitization, gross and histopathology, dermal reproductive and developmental toxicity, photosensitization, and genotoxicity. The CIR also stipulates that these ingredients must not exhibit metabolic or endocrine activity and must be demonstrably free of detectable pathogenic viruses or infectious agents. The European Union cosmetics directive (Regulation No. 1223/2009) explicitly prohibits human-derived ingredients due to concerns regarding the transmission of human spongiform encephalopathies and viral diseases such as HIV. The FDA advises against identifying placenta-derived ingredients as 'placental extract' if depleted of hormones, to avoid misleading consumers. EWG also lists high contamination concerns and use restrictions for this ingredient.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite proposed benefits, Hydrolyzed Human Placental Protein is strongly advised against due to insufficient safety data, strict regulatory prohibitions in the EU, and significant concerns regarding contamination and potential disease transmission.
Related
Similar Ingredients
Finding similar ingredients…